Reinach, Switzerland

Paulfaello Hebeisen

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulfaello Hebeisen. Retrieved from https://idiyas.com/inventor/paulfaello-hebeisen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paulfaello Hebeisen: Innovator in DNA Gyrase Inhibitors

Introduction

Paulfaello Hebeisen is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of DNA gyrase inhibitors. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Hebeisen holds a patent for "DNA gyrase inhibitors, process for their manufacture and pharmaceutical." This patent includes compounds of a specific formula, where P is hydroxy and T is a defined group. These compounds are essential in the preparation of DNA gyrase inhibitors, which play a crucial role in combating bacterial infections.

Career Highlights

Throughout his career, Paulfaello Hebeisen has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has been instrumental in developing new therapeutic agents that target bacterial DNA replication processes.

Collaborations

Hebeisen has collaborated with notable colleagues, including Mikio Arisawa and Erwin Gotschi. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Paulfaello Hebeisen's contributions to the development of DNA gyrase inhibitors highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the field positively, paving the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…